Secret unveiled: CRISPR Therapeutics’ Founder & CEO will close Refresh

This is so awesome! I’m extremely proud to tell you that we will have Rodger Novak closing Labiotech Refresh on May 24th in Berlin.


CRISPR is a real revolution in Biotech and gene editing. It’s even considered by many as the discovery of the century and should soon get the Nobel prize. This extremely powerful technology is also moving toward translation into therapeutics.

The leading European company in the field is…CRISPR Therapeutics, co-founded by Novak himself, Emmanuelle Charpentier (one of the co-discoverer of the technology) and Shaun Foy.


Rodger Novak, CEO of CRISPR Therapeutics, Breakthrough Prize laureates Jennifer Doudna and Emmanuelle Charpentier with Innovative Genomics Initiative Scientific Director Jacob Corn. (Credit: Rodger Novak / IGI)

It raised €80M in series A and B rounds, signed a monster €2.3Bn deal with Vertex and is on its way to being one of the leading gene therapy company worldwide.

I’m really excited to interview him on stage in one of our 5 fireside chats!

The only thing you need to do is to get your ticket before Friday.


Feature Image Credit: Remix of Graphics by Labiotech & Rodger Novak (Source: Rodger Novak)

Let's Continue The Conversation

Feel free to send us comments about this article to and/or comment on that article on social media.

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.